Loading provider…
Loading provider…
Gynecologic Oncology Physician in Los Angeles, CA
NPI: 1386649713Primary Employer
USC Care Medical Group, Inc
keckmedicine.org
HQ Phone
Get M.D. Lynda's Phone NumberMobile
Get M.D. Lynda's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1991 - 2026
TX State Medical License
1990 - 2003

American Board of Obstetrics and Gynecology
Obstetrics & Gynecology

American Board of Obstetrics and Gynecology
Gynecologic Oncology
University of Texas M D Anderson Cancer Center
Fellowship • Gynecologic Oncology
1989 - 1991
UMass Chan Medical School
umassmed.edu
Residency • Obstetrics and Gynecology
1984 - 1989
McGill University Faculty of Medicine
Medical School
Until 1984
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 69 | 133 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 44 | 131 |
| 3 | 99212Established patient outpatient visit, total time 10-19 minutes | 12 | 15 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 11 | 16 |
[Long-term outcome of surgical treatment of patients with esophageal cancer].
Authors: Miroshnikov, B I, Pavelets, K V, Marochkin, N E, Roman, L D, Shostka, K G, Shiriaev, Iu N
Journal: Vestn Khir Im I I Grek
Authors: Shurkus, V E, Roman, L D, Shurkus, E A
Journal: Vestn Khir Im I I Grek
Lymph node dissection in esophageal cancer
Authors: Miroshnikov Bi, Lynda D. Roman, Pavelets Kv, Shostka Kg, Burakov Vv
Publication Date: 1999-01
Lead Sponsor: University of Southern California
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: eribulin mesylate
Lead Sponsor: University of Southern California
Collaborators: National Cancer Institute (NCI), Brooklyn ImmunoTherapeutics, LLC
Intervention / Treatment: OTHER: Placebo, OTHER: Laboratory Biomarker Analysis, PROCEDURE: Therapeutic Conventional Surgery, DRUG: Cyclophosphamide, DRUG: Omeprazole, BIOLOGICAL: IRX-2, DIETARY_SUPPLEMENT: Multivitamin, DRUG: Indomethacin
Lead Sponsor: Kevelt AS
Collaborators: Pharmasyntez
Intervention / Treatment: DRUG: Sodium cridanimod